New Biomarkers for Insulin Resistance and Diabetes
Author Information
Author(s): Lau Cia-Hin, Muniandy Sekaran
Primary Institution: Department of Molecular Medicine, Faculty of Medicine, University of Malaya
Hypothesis
The study aims to propose novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes as diagnostic biomarkers for insulin resistance, type 2 diabetes, and metabolic syndrome.
Conclusion
The novel AR and IRAR indexes are effective and reliable diagnostic biomarkers for identifying individuals at risk of developing type 2 diabetes and metabolic syndrome.
Supporting Evidence
- The AR index was more strongly associated with increased risk of T2DM and MS than adiponectin and resistin levels alone.
- The IRAR index was formulated to provide a better prediction of insulin resistance than existing indexes.
- Both AR and IRAR indexes showed high precision and reproducibility in diagnosing insulin sensitivity.
Takeaway
This study created new ways to measure insulin resistance using two indexes that combine levels of certain hormones, which can help doctors find out who might get diabetes or metabolic syndrome.
Methodology
A case control study measuring fasting serum total adiponectin and resistin levels along with other metabolic parameters in Malaysian men aged 40-70.
Potential Biases
Potential residual confounding due to the observational nature of the study.
Limitations
The findings may not be generalizable beyond Malaysian men, and the study design does not allow for causal inferences.
Participant Demographics
809 Malaysian men aged 40-70, including Malay, Chinese, and Indian ethnic groups.
Statistical Information
P-Value
1.45 × 10-9
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website